X10 Analytics | The Data Behind X10 Therapy
Research Provides Insight Into the Value of the X10
The data below is based on numerous research studies about X10 Therapy that have been conducted over the past 15 years. You can review this research here: X10 THERAPY RESEARCH & DATA. The conclusion of this work is that the X10 bridges The Rehabilitation Gap in the United States. For those whose recovery has stalled or is failing the X10 can stand in and fix the problem before the recovery window has closed.
To use the chart below be sure to click on the FOUR TABS IN THE TABLE: EXECUTIVE SUMMARY, CLINICAL EFFICACY, MECHANISM, IMPACT.
The Rehabilitation Gap
Standard recovery often fails not due to surgery, but due to the "Rehabilitation Gap"—the disparity between mechanical success and functional mobility. X10 bridges this by preventing arthrofibrosis.
The Problem: Arthrofibrosis
Rapid scar tissue formation in the first 2-4 weeks causes permanent stiffness. Standard CPM machines are passive and often fail to prevent this adhesion. The X10 utilizes active biofeedback to target this "Golden Window."
Comparative Clinical Data
Outcomes vs. Standard Physical Therapy (CPM)
Days to Reach 110° Flexion
Recovery Trajectory (Flexion/Week)
Eliminating Complications
The incidence of Manipulation Under Anesthesia (MUA) drops from the national average of ~5% to <0.5% with X10. This effectively eliminates one of the costliest and most traumatic complications.
Why Standard Therapy Stalls
The difference between Pain-Guarding and Recovery.
Standard Care: The Pain Loop
X10 PMKR: Biofeedback
Socio-Economic Impact
Weeks to Return to Activity
Cost Efficiency
"Patients reported higher satisfaction due to autonomy and control over their own pain."
